The Emergence of a European Biotechnology Cluster: The Case of Medicon Valley
2007 (English)In: Cluster Genesis: Technology-Based Industrial Development, Oxford University Press , 2007Chapter in book (Other academic)
This chapter examines the forces that sparked the emergence of a leading European biotechnology cluster - Medicon Valley. This cluster displays one characteristic feature which separates it from most other biotechnology clusters: its geographical location stretches over two countries: parts of Sweden and Denmark. The emergence of the Medicon Valley biotechnology cluster seems to have followed a somewhat different path than the biotech clusters in the United States. Whereas entrepreneurs orchestrated the emergence of clusters in the United States, universities played a crucial role in the Medicon Valley case and entrepreneurs entered - and reinforced - the process in a later stage. The more dynamic and fast growing biotechnology sector in Denmark is argued to be partly policy driven, partly associated with cultural differences.
Place, publisher, year, edition, pages
Oxford University Press , 2007.
IdentifiersURN: urn:nbn:se:kth:diva-161856DOI: 10.1093/acprof:oso/9780199207183.003.0007ScopusID: 2-s2.0-84920041858ISBN: 9780191708886OAI: oai:DiVA.org:kth-161856DiVA: diva2:796376
QC 201503192015-03-192015-03-172015-03-19Bibliographically approved